Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%

JAMA

Volumn 311, Issue 21, 2014, Pages 2209-2215

  Al Khatib, Sana M ^a,b   Hellkamp, Anne S ^a   Fonarow, Gregg C ^c   Mark, Daniel B ^a,b   Curtis, Lesley H ^a,b   Hernandez, Adrian F ^a,b   Anstrom, Kevin J ^a   Peterson, Eric D ^a,b   Sanders, Gillian D ^a   Al Khalidi, Hussein R ^a   Hammill, Bradley G ^a   Heidenreich, Paul A ^d   Hammill, Stephen C ^a,b,e  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RESPONSE; CAUCASIAN; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MEDICARE; PROPENSITY SCORE; REGISTRIES; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84901769083     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.5310     Document Type: Article

References (20)

1. Hellermann JP, Jacobsen SJ, Redfield MM, Reeder GS, Weston SA, Roger VL. Heart failure after myocardial infarction: clinical presentation and survival. Eur J Heart Fail. 2005;7(1):119-125. (Pubitemid 40092503)
2. Weir RA, McMurray JJ. Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Curr Heart Fail Rep. 2006;3(4):175-180.
3. MERIT HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001-2007.
4. Moss AJ, Hall WJ, Cannom DS, et al Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335(26):1933-1940. (Pubitemid 26428217)
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G; Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341(25):1882-1890.
6. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883. (Pubitemid 34984635)
7. Kadish A, Dyer A, Daubert JP, et al Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151-2158. (Pubitemid 38637995)
8. Bardy GH, Lee KL, Mark DB, et al Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237. (Pubitemid 40110811)
9. Hammill SC, Stevenson LW, Kadish AH, et al. Review of the registry's first year, data collected, and future plans. Heart Rhythm. 2007;4(9):1260-1263. (Pubitemid 47324135)
10. Kremers MS, Hammill SC, Berul CI, et al. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013;10(4):e59-e65.
11. Hammill SC, Kremers MS, Kadish AH, et al. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm. 2009;6(9):1397-1401.
12. Messenger JC, Ho KK, Young CH, et al NCDR Science and Quality Oversight Committee Data Quality Workgroup. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. J Am Coll Cardiol. 2012;60(16):1484-1488.
13. Fonarow GC, Abraham WT, Albert NM, et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148(1):43-51. (Pubitemid 38900479)
14. Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J. 2009;157(6):995-1000.
15. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39(1):33-38.
16. Epstein AE, DiMarco JP, Ellenbogen KA, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Circulation. 2008;117(21):e350-e408. (Pubitemid 351771339)
17. Al-Khatib SM, Han JY, Edwards R, et al. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? Int J Cardiol. 2014;172(1):253-254.
18. Curtis LH, Greiner MA, Hammill BG, et al. Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med. 2008;168(22):2481-2488.
19. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA. 2011;306(15):1669-1678.
20. Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Køber L; DIAMOND Study Group. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J. 2003;24(9):863-870. (Pubitemid 36528566)